A randomized, double-blind parallel group study comparing Casodex 50mg placebo to casodex 50mg plus dutasteride 3.5mg administered for 18 months to men with prostate cancer who have failed first-line androgen deprivation therapy (assessed by rising PSA)
|Effective start/end date||3/18/08 → 12/31/12|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.